Increased Liver Fat Content and Unfavorable Glucose Profiles in Subjects Without Diabetes-Reference-Cited by-同舟云学术

Increased Liver Fat Content and Unfavorable Glucose Profiles in Subjects Without Diabetes

Published:2011-02 Issue:2 Volume:13 Page:149-155
ISSN:1520-9156
Container-title:Diabetes Technology & Therapeutics
language:en
Short-container-title:Diabetes Technology & Therapeutics

Author:

Bian Hua¹,Yan Hongmei¹,Zeng Mengsu²,Rao Shengxiang²,Yao Xiuzhong²,Zhou Jian³,Jia Weiping³,Gao Xin¹

Affiliation:

1. Department of Endocrinology and Metabolism, Zhongshan Hospital, Fudan University, Shanghai, China.

2. Department of Radiology, Zhongshan Hospital, Fudan University, Shanghai, China.

3. Department of Endocrinology and Metabolism, Shanghai Jiao Tong University Affiliated Sixth People's Hospital, Shanghai Diabetes Institute, Shanghai Clinical Center for Diabetes, Shanghai, China.

Publisher

Mary Ann Liebert Inc

Subject

Medical Laboratory Technology,Endocrinology,Endocrinology, Diabetes and Metabolism

Link

http://www.liebertpub.com/doi/pdf/10.1089/dia.2010.0101

Reference30 articles.

1. Nonalcoholic Fatty Liver Disease

2. Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome

3. Prevalence of hepatic steatosis in an urban population in the United States: Impact of ethnicity

4. Aminotransferase and gamma-glutamyl transpeptidase levels in obesity are associated with insulin resistance and the metabolic syndrome

5. Decreased insulin secretion in type 2 diabetes: a problem of cellular mass or function?

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Two-week continuous glucose monitoring-derived metrics and degree of hepatic steatosis: a cross-sectional study among Chinese middle-aged and elderly participants;Cardiovascular Diabetology;2024-08-31

2. Glycemic variability assessed using continuous glucose monitoring in individuals without diabetes and associations with cardiometabolic risk markers: A systematic review and meta-analysis;Clinical Nutrition;2024-04

3. Metabolically healthy obesity: Is it really healthy for type 2 diabetes mellitus?;World Journal of Diabetes;2022-02-15

4. Portal venous and hepatic artery hemodynamic variation in non-alcoholic fatty liver disease;Egyptian Liver Journal;2021-06-30

5. Thrombospondin 1 improves hepatic steatosis in diet-induced insulin-resistant mice and is associated with hepatic fat content in humans;EBioMedicine;2020-07